Latest Kaiser Health News Stories
Critics say the Trump administration failed to properly vet Dr. Robert Redfield as they attribute a pattern of “ethically and morally questionable behavior” to him.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the problems that are making congressional efforts to pass legislation to stabilize the individual insurance market a long shot.
The federal Centers for Medicare & Medicaid Services advised the state that its plan to offer state-based insurance plans falls short of the Obamacare rules and could result in penalties for insurers.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week’s spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
The HHS civil rights division refocuses on the rights of health care providers who have moral objections to treatments such as abortion or sterilization, alarming critics.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Stephanie Armour of The Wall Street Journal and Julie Appleby of Kaiser Health News discuss the Trump administration’s proposed regulation that would allow the expansion of short-term health insurance policies that do not comply with all the requirements of the Affordable Care Act. The panelists also talk about federal funding (or not) of public health research around guns.
Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.
Focus turns to whether the Trump administration will challenge Idaho’s move to allow such plans to be sold to individuals.
Many eyes are on the Trump administration to see how officials respond to Idaho’s approach to health insurance, which flouts some aspects of the Affordable Care Act.
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
Allowing states to mandate that non-disabled Medicaid enrollees work as a condition for coverage would mark one of the biggest changes to the program since it began more than 50 years ago. A decision on the first of the state requests could come within days.
Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
A series of moves by the Trump administration has sought to deter people from signing up for insurance on the health law’s marketplaces.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.
The shutdown, which raised protests from navigator groups, will occur from midnight Saturday to 12 p.m. Sunday on all but one weekend.
The federal government plans to spend millions of dollars less this year on advertising and outreach efforts to support the health law’s open enrollment period, which starts Nov. 1.